HealthTree Logo
search more_vert
App Logo
close
person Sign In / Create Account

Ashkan Emadi, MD

Hematologist Oncologist, Professor of Medicine, Associate Director for Clinical Research, University of Maryland Greenebaum Comprehensive Cancer Center (UMGCCC), & Director of Translational Genomics Laboratory, University of Maryland School of Medicine (UMSOM)

12 years treating AML

Clinical Expertise

Dr. Emadi directs cutting-edge translational patient-centered research focused on exploiting cancer metabolism particularly the glutamine dependency of cancers. His discovery of the combination of venetoclax (Ven) and pegcrisantaspase (PegC) as a novel, well tolerated and highly active regimen in vivo for the treatment of AML with a complex karyotype is potentially paradigm shifting for the treatment of poor risk AML.

Location

University Of Maryland School Of Medicine: 22 S Greene St, Baltimore, MD 21201, USA

Get the latest thought leadership on AML delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for AML Newsletter" for AML news, life with AML stories, AML clinical trials, AML 101 articles and events with AML experts.

Thanks to our HealthTree Community for AML Sponsors:

Jazz Pharmaceuticals
AbbVie
Amgen
Genentech
Bristol Myers Squibb

Follow Us

facebook instagram twitter youtube